 There are no studies in the Asia-Pacific region that explore the burden of care as it relates to asthma, AR, COPD and rhinosinusitis in adults who present to Health Care Practitioners (HCPs) under one standard protocol.
Ea r pa i n 1 1 1 3  Prevalence of respiratory diseases is increasing in the Asia-Pacific region. [2] [3] [4] [5]  There are no studies in the Asia-Pacific region that explore the burden of care as it relates to asthma, AR, COPD and rhinosinusitis in adults who present to Health Care Practitioners (HCPs) under one standard protocol.
 Cough is the most common symptom for patients presenting in primary care in the US and has a significant impact on quality of life. 6  Cough is one of the main symptoms for patients presenting with asthma and COPD and is a common symptom associated with AR and rhinosinusitis. 7, 8  Given the importance of cough as a 'signaling' symptom in respiratory diseases, it is vital to assess the frequency with which cough is present in patients visiting HCPs.
 Among all symptoms reported, cough or coughing up phlegm was the most frequently reported symptom (57%), followed by sneezing (48%) and blocked nose or congestion (44%).
 Cough or coughing up phlegm was the most frequently reported symptom for patients with a primary diagnosis of COPD (73%) and asthma (61%), second for participants with rhinosinusitis (59%), and fifth for participants with AR (47%) (Figure 2 ).
 A cross-sectional, observational study, Asia-Pacific Burden of Respiratory Diseases (APBORD), was conducted to examine the burden of disease in adults with respiratory diseases across 6 countries -India, Korea, Malaysia, Singapore, Taiwan, and Thailand.
 Subjects were recruited from a total of 22 sites between 31 October 2012 and 13 October 2013. The study was approved by Ethics Committees in each jurisdiction.
 Consecutive adult patients presenting to each study site were assessed by the physician during a routine consultation. Eligibility criteria included age ≥ 18 years and receiving care for a primary diagnosis of asthma, AR, COPD or rhinosinusitis.  This study shows that the four diseases of asthma, AR, COPD and rhinosinusitis represent a significant percentage of all respiratory disorders presenting to HCPs in the Asia Pacific region.
Introduction Cough as a key symptom in Asthma, Allergic Rhinitis, COPD and Rhinosinusitis and its impact in Asia
 Cough was a prominent symptom and major driver of medical care not only for patients with COPD and asthma, but also for rhinosinusitis and AR.
 Patients presenting with cough should be investigated more comprehensively for any underlying respiratory disorders to help with appropriate disease management.  A total of 13,902 patients diagnosed with a respiratory disease were screened for inclusion. Of these, 7,030 (50.6%) were diagnosed with asthma, AR, COPD or rhinosinusitis, and therefore, were eligible to enroll in the study. Of the 7,030 eligible patients, 5,250 (74.7%) consented and were enrolled in the study.
 The mean (SD) age of enrolled patients was 48.8 (17.6) years and 53% were females. Chinese was the most frequently reported ethnicity (28%). Seventy percent of patients had never smoked. Of the patients to have ever smoked (30%), 33% were current smokers.
 Overall, the highest percentage of patients receiving care for a respiratory disorder had a primary diagnosis of AR (14.0%, 95%CI: 13.4%, 14.6%), followed by asthma (13.5%, 95%CI: 12.9%, 14.1%), rhinosinusitis (5.4%, 95%CI: 4.6%, 5.3%) and COPD (4.9%, 95%CI: 5.0%, 5.7%) (Figure 1 ).
 The proportion of patients receiving care for asthma, AR, COPD, or rhinosinusitis varied between each country (Table 1 ).  Overall, cough or coughing up phlegm was reported as the main reason for the medical visit by 23% of participants.
 Cough was the most frequently reported main reason for seeking medical care among participants with a primary diagnosis of COPD (43%), and Asthma (33%), and third for participants with a primary diagnosis of rhinosinusitis (13%) and AR (11%) (Figure 3 ). 
